The development of new therapies, especially in the era of targeted treatments and personalized medicine, is driven by understanding the underlying cell biology, molecular biology and biochemistry of tumor cells and their surrounding microenvironments.
The Cancer Biology research program aims to understand fundamental molecular mechanisms that define normal and neoplastic cell growth to identify and characterize molecules, pathways and processes that drive cancer growth and progression. Members hone their efforts on the cancers that most affect people in the cancer center’s catchment area.
Under the leadership of Tomoo Iwakuma, MD, PhD, Linheng Li, PhD, Kristi Neufeld, PhD, and Sufi Thomas, PhD, Cancer Biology members work closely with the Drug Discovery, Delivery & Experimental Therapeutics Research Program as these basic findings can serve as useful biomarkers or new targets for treatment.
Targeting Liver Inflammation
Become a cancer
Gain access to a network for researchers and members-only grant opportunities. Become a member of The University of Kansas Cancer Center.